Do beta2 microglobulin levels affect survival of newly diagnosed myeloma patients with translocation t(4;14) or 17p13 deletion treated with conventional chemotherapy?
about
Trisomies in multiple myeloma: impact on survival in patients with high-risk cytogenetics.Incorporation of the bone marker carboxy-terminal telopeptide of type-1 collagen improves prognostic information of the International Staging System in newly diagnosed symptomatic multiple myeloma.Clinical and biological features of t(4;14) multiple myeloma: a prospective study
P2860
Do beta2 microglobulin levels affect survival of newly diagnosed myeloma patients with translocation t(4;14) or 17p13 deletion treated with conventional chemotherapy?
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Do beta2 microglobulin levels ...... patients with translocation t
@nl
Do beta2 microglobulin levels ...... ith conventional chemotherapy?
@en
type
label
Do beta2 microglobulin levels ...... patients with translocation t
@nl
Do beta2 microglobulin levels ...... ith conventional chemotherapy?
@en
prefLabel
Do beta2 microglobulin levels ...... patients with translocation t
@nl
Do beta2 microglobulin levels ...... ith conventional chemotherapy?
@en
P356
P1433
P1476
Do beta2 microglobulin levels ...... ith conventional chemotherapy?
@en
P2093
P2860
P2888
P304
P356
10.1038/SJ.LEU.2405009
P577
2007-11-29T00:00:00Z